Page last updated: 2024-10-31
mitotane and Dyspnea
mitotane has been researched along with Dyspnea in 1 studies
Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.
Dyspnea: Difficult or labored breathing.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitotane is a cytostatic antineoplastic agent that is used in the treatment of adrenocortical carcinoma and Cushing's syndrome." | 3.88 | Mitotane-induced dyspnoea: an unusual side effect. ( Adhikari, S; Amjad, W; Farooq, AU; Kochar, T, 2018) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Farooq, AU | 1 |
| Amjad, W | 1 |
| Kochar, T | 1 |
| Adhikari, S | 1 |
Other Studies
1 other study available for mitotane and Dyspnea
| Article | Year |
|---|---|
Mitotane-induced dyspnoea: an unusual side effect.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aged; Antineoplastic Agents, Hormonal; Diagnosis | 2018 |